Fingerprint
Dive into the research topics of 'Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis*'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis*
K. B. Gordon, M. Lebwohl, K. A. Papp, H. Bachelez, J. J. Wu, R. G. Langley, A. Blauvelt, B. Kaplan, M. Shah, Y. Zhao, R. Sinvhal, K. Reich
Research output: Contribution to journal › Article › peer-review
62
Citations
(Scopus)